Free Depression and Anxiety Tests: A Side-by-Side Comparison Guide

When depression shows up, anxiety is usually not far behind. More than half of people with a depressive disorder also meet the criteria for an anxiety disorder - yet most free screening tools still test for one condition at a time. A depression-only test can miss a significant share of what is actually happening.

What follows is a focused comparison of dual-condition screeners: tools that check for both depression and anxiety in a single session. Each major validated instrument is laid out head-to-head, with enough detail to help you choose based on your specific situation.

According to the Anxiety and Depression Association of America (ADAA), comorbid depression and anxiety is one of the most common presentations in clinical practice. Single-condition tests are built for a simpler picture than most people are actually living with. That is the gap these tools address.

Quick Comparison: Free Dual-Condition Screening Tools

The table below covers the most widely validated free tools that screen for both conditions at once.

All four tools are freely available. None require payment, registration, or a clinical setting to use. They differ considerably, though, in depth, purpose, and design philosophy.

Detailed Breakdown of Each Tool

PHQ-4: The Fastest Validated Combo Screen

The PHQ-4 is the shortest validated dual-condition screener available. It combines the PHQ-2 (two depression questions) and the GAD-2 (two anxiety questions) into a single 4-item instrument. You can complete it in under two minutes.

That speed makes it ideal when time is tight. Busy clinics, workplace wellness check-ins, and school counselor intake forms all benefit from its brevity. Despite being just four questions, the tool has solid clinical backing.

According to the National Institute of Mental Health (NIMH), the PHQ family of instruments is widely used in clinical research and public health surveillance. The PHQ-4 is one of the most efficient entry points into that validated toolkit. It rarely appears on depression-only screening pages, which makes it an overlooked option despite strong clinical credentials.

Limitation: The PHQ-4 is a screener, not a diagnostic tool. A high score means you should follow up - it does not confirm a diagnosis.

Take a free depression screening here or explore the full PHQ-9 for a more detailed view of depressive symptoms.

DASS-21: The Most Comprehensive Free Tool

The Depression Anxiety Stress Scales (DASS-21) go further than any other free instrument on this list. It covers three dimensions: depression, anxiety, and stress. That third dimension gives you a more complete read than any two-condition tool can provide.

The DASS-21 was developed at the University of New South Wales. It has been peer-reviewed and validated across more than 20 languages - a depth of research that sets it apart from many app-based quizzes, which often lack published psychometric data entirely.

Many popular mental health apps offer quizzes that look clinical but have no published validation studies behind them. The DASS-21 has a transparent evidence base you can look up and verify. That is a meaningful difference when you are making decisions about your mental health.

The DASS-21 is freely available for clinical and research use. It takes about five to ten minutes and suits anyone who wants more than a basic screen.

Best for: People who want detail, researchers, therapists looking for a free intake option, and HR wellness programs that need a single validated instrument covering all three dimensions at once.

HADS: Designed to Separate Mood from Physical Symptoms

The Hospital Anxiety and Depression Scale (HADS) was built to solve a specific problem. Many depression and anxiety tools include somatic items - questions about sleep, appetite, or fatigue. In medical settings, those physical symptoms often reflect an underlying illness rather than a mood disorder.

The HADS removes those overlapping somatic items deliberately. This makes it more accurate for people with chronic illness, recent surgery, or other physical health conditions. It separates mood symptoms from physical ones in a way that most other tools do not attempt.

The HADS has 14 questions - seven for anxiety and seven for depression. Each subscale is scored independently, so you get separate results for each condition rather than a single combined score.

Best for: Anyone in a medical setting, people managing chronic illness, and clinicians who need to screen without confounding physical symptoms.

PHQ-9 + GAD-7: The Detailed Clinical Standard

The PHQ-9 and the GAD-7 are the most widely used validated tools for depression and anxiety in clinical practice. They are typically administered separately, but pairing them gives you a thorough combined screen.

The PHQ-9 covers the nine DSM criteria for major depression. The GAD-7 covers seven anxiety symptoms. Together, they provide detailed severity scores for both conditions - which makes them useful for tracking changes over time, not just for a one-off screen.

The National Institute of Mental Health (NIMH) provides public-domain descriptions of both instruments, and both are freely available online without restriction.

Limitation: Running both tools takes more time than the PHQ-4 or HADS. For workplace or school settings where survey fatigue is a concern, the shorter combo tools may be more practical.

Comorbidity: Why Single-Condition Tests Fall Short

Comorbid anxiety and depression is not a rare edge case - it is the most common clinical pattern. According to the Anxiety and Depression Association of America (ADAA), more than 50% of people with a depressive disorder also meet criteria for an anxiety disorder.

When you use a standalone depression tool - like the PHQ-9 alone - you may miss anxiety-driven presentations. Someone experiencing panic, avoidance, and worry alongside low mood may score only moderately on a depression scale without the anxiety component being captured at all.

Combined tools reduce false negatives by capturing the full symptom picture. They give clinicians and individuals a more accurate read of what is happening - particularly for comorbid presentations, where anxiety and depression interact and amplify each other.

For HR wellness programs and school counselors, there is a practical benefit beyond accuracy. Administering two separate instruments takes longer and increases survey fatigue. A single validated combo tool like the DASS-21 or PHQ-4 handles both conditions in one session without adding to participant burden.

Verdict: Which Tool Should You Use?

None of these tools replace a clinical diagnosis. They are starting points - not endpoints. If any result suggests moderate or severe symptoms, the next step is to speak with a licensed mental health professional.

Taking Action After Your Results

A screening result - whether mild, moderate, or severe - is information, not a verdict. It tells you whether further support is worth exploring. What you do next matters more than the number on the screen.

If you score high on both the depression and anxiety sections of any combo tool, consider these steps. First, write down your scores and the date - this gives your provider a baseline to work from. Second, look for an integrated treatment approach. Cognitive Behavioral Therapy (CBT) is one of the most researched options for comorbid presentations, addressing both conditions at once rather than treating them in sequence.

Third, do not wait for symptoms to become severe before asking for help. Early intervention is consistently more effective than delayed treatment. The SAMHSA National Helpline (1-800-662-4357) is free, confidential, and available 24 hours a day. It is a good first call if you are unsure where to start.

Frequently Asked Questions

Explore free mental health resources and local support options